Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) board of directors agreed on the distribution of a 7.5% cash dividend, at SAR 0.75 per share, for H1 2024, the company said in a statement to Tadawul.
Dividend Details (H1 2024) |
|
Capital |
SAR 200.00 mln |
Number of Shares |
20.00 mln |
Total Dividend |
SAR 15.00 mln |
Percentage of Capital |
7.5% (SAR 0.75 per share) |
Record Date |
Sept. 1, 2024 |
Payment Date |
Sept. 15, 2024 |
According to data available to Argaam, this will be the first dividend distribution for the company after being listed on TASI last February.
Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
30/07/2024 | 01/09/2024 | 15/09/2024 | 15.00 | 0.75 |
Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
---|---|---|---|
Last 3 Financial years | N/A | N/A | N/A |
Last 5 Financial years | N/A | N/A | N/A |
Last 10 Financial years | N/A | N/A | N/A |
P/E (TTM) | 33.66 |
P/E Before Unusual Items (TTM) | 33.66 |
P/BV | 8.08 |
Dividend Yield | - |
Market Cap. (M) | 2,548.00 |
Return on Average Assets | - |
Return on Average Equity | 25.85 % |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}